These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

260 related articles for article (PubMed ID: 37152956)

  • 1. A bibliometric and visualized research on global trends of immune checkpoint inhibitors related complications in melanoma, 2011-2021.
    Zhang H; Shi Y; Ying J; Chen Y; Guo R; Zhao X; Jia L; Xiong J; Jiang F
    Front Endocrinol (Lausanne); 2023; 14():1164692. PubMed ID: 37152956
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Research hot spots and trends in endocrine-related adverse events caused by immune checkpoint inhibitors: a bibliometric analysis and visualization research.
    Zhao J; Liu G; Yang X; Zhang C; Han B; Jiang M
    Front Endocrinol (Lausanne); 2024; 15():1253832. PubMed ID: 38686201
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bibliometric analysis of rheumatic immune related adverse events associated with immune checkpoint inhibitors.
    Zeng L; Ma G; Chen K; Zhou Q
    Front Immunol; 2023; 14():1242336. PubMed ID: 37869006
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Research Trends in Immune Checkpoint Blockade for Melanoma: Visualization and Bibliometric Analysis.
    Xu Y; Jiang Z; Kuang X; Chen X; Liu H
    J Med Internet Res; 2022 Jun; 24(6):e32728. PubMed ID: 35759331
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immune-related adverse events: A bibliometric analysis.
    Jiang ST; Liu YG; Zhang L; Sang XT; Xu YY; Lu X
    Front Immunol; 2022; 13():1096806. PubMed ID: 36591239
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Knowledge mapping and current trends of immunotherapy for prostate cancer: A bibliometric study.
    Zhong W; Shen Z; Wu Y; Mao X; Kong J; Wu W
    Front Immunol; 2022; 13():1014981. PubMed ID: 36389756
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Global research trends on the links between gut microbiota and cancer immunotherapy: A bibliometric analysis (2012-2021).
    Yang S; Zhao S; Ye Y; Jia L; Lou Y
    Front Immunol; 2022; 13():952546. PubMed ID: 36090978
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bibliometric analysis of research trends on the combination of immune checkpoint inhibitors and PARP inhibitors in solid tumors.
    Tan Y; Song Q
    Heliyon; 2024 Jan; 10(2):e24452. PubMed ID: 38293546
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Knowledge structure and hotspots research of glioma immunotherapy: a bibliometric analysis.
    Yuan Y; Su Y; Wu Y; Xue Y; Zhang Y; Zhang Y; Zheng M; Chang T; Qu Y; Zhao T
    Front Oncol; 2023; 13():1229905. PubMed ID: 37671057
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunotherapy for ocular melanoma: a bibliometric and visualization analysis from 1991 to 2022.
    Tan Y; Lu Y; Chen S; Zou C; Qin B
    Front Oncol; 2023; 13():1161759. PubMed ID: 37324010
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mapping the intellectual structure and landscape of colorectal cancer immunotherapy: A bibliometric analysis.
    Ou QL; Chang YL; Liu JH; Yan HX; Chen LZ; Guo DY; Zhang SF
    Hum Vaccin Immunother; 2024 Dec; 20(1):2323861. PubMed ID: 38497584
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Research Trends in the Application of Artificial Intelligence in Oncology: A Bibliometric and Network Visualization Study.
    Wu T; Duan Y; Zhang T; Tian W; Liu H; Deng Y
    Front Biosci (Landmark Ed); 2022 Aug; 27(9):254. PubMed ID: 36224012
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immune regulation and the tumor microenvironment in anti-PD-1/PDL-1 and anti-CTLA-4 therapies for cancer immune evasion: A bibliometric analysis.
    Huang Y; Chen Z; Shen G; Fang S; Zheng J; Chi Z; Zhang Y; Zou Y; Gan Q; Liao C; Yao Y; Kong J; Fan X
    Hum Vaccin Immunother; 2024 Dec; 20(1):2318815. PubMed ID: 38419524
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Emerging trends of BCG immunotherapy for bladder cancer in last decade: a bibliometric and visualization analysis.
    Chen X; He F; Zhang W; Fu Y; Cao Z
    Front Oncol; 2023; 13():1092969. PubMed ID: 37124495
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bibliometric analysis of global research trends on male osteoporosis: a neglected field deserves more attention.
    Wu H; Sun Z; Tong L; Wang Y; Yan H; Sun Z
    Arch Osteoporos; 2021 Oct; 16(1):154. PubMed ID: 34632530
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tyrosine Kinase Inhibitors for Renal Cell Carcinoma: A Bibliometric Analysis via CiteSpace from 2000 to 2022.
    Xu J; Huang Z; Gao S; Deng G; Di J
    Urol Int; 2023; 107(8):755-771. PubMed ID: 37454653
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Knowledge mapping of targeted immunotherapy for myasthenia gravis from 1998 to 2022: A bibliometric analysis.
    Su Y; Ruan Z; Wang R; Hao S; Tang Y; Huang X; Gao T; Li Z; Chang T
    Front Immunol; 2022; 13():998217. PubMed ID: 36248874
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Emerging trends and focus on immune checkpoint inhibitors for non-small cell lung cancer treatment: visualization and bibliometric analysis.
    Zhang Y; Lu L; Zheng R
    Front Pharmacol; 2023; 14():1140771. PubMed ID: 37214445
    [No Abstract]   [Full Text] [Related]  

  • 19. Mapping knowledge landscapes and emerging trends of the biomarkers in melanoma: a bibliometric analysis from 2004 to 2022.
    Wan Y; Shen J; Hong Y; Liu J; Shi T; Cai J
    Front Oncol; 2023; 13():1181164. PubMed ID: 37427124
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Worldwide research trends on tumor burden and immunotherapy: a bibliometric analysis.
    Zhang L; Zheng H; Jiang ST; Liu YG; Zhang T; Zhang JW; Lu X; Zhao HT; Sang XT; Xu YY
    Int J Surg; 2024 Mar; 110(3):1699-1710. PubMed ID: 38181123
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.